These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Noninvasive quantification of the differential portal and arterial contribution to the liver blood supply from PET measurements using the 11C-acetate kinetic model. Chen S, Feng D. IEEE Trans Biomed Eng; 2004 Sep; 51(9):1579-85. PubMed ID: 15376506 [Abstract] [Full Text] [Related]
5. Early dynamic 18F-FDG PET to detect hyperperfusion in hepatocellular carcinoma liver lesions. Schierz JH, Opfermann T, Steenbeck J, Lopatta E, Settmacher U, Stallmach A, Marlowe RJ, Freesmeyer M. J Nucl Med; 2013 Jun; 54(6):848-54. PubMed ID: 23528383 [Abstract] [Full Text] [Related]
6. Tracer kinetic modeling of 11C-acetate applied in the liver with positron emission tomography. Chen S, Ho C, Feng D, Chi Z. IEEE Trans Med Imaging; 2004 Apr; 23(4):426-32. PubMed ID: 15084068 [Abstract] [Full Text] [Related]
7. Does dual-time-point 18F-FDG PET/CT scan add in the diagnosis of hepatocellular carcinoma? Wu B, Zhao Y, Zhang Y, Tan H, Shi H. Hell J Nucl Med; 2017 Apr; 20(1):79-82. PubMed ID: 28315913 [Abstract] [Full Text] [Related]
8. Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma. Pant V, Sen IB, Soin AS. Nucl Med Commun; 2013 Aug; 34(8):749-57. PubMed ID: 23689586 [Abstract] [Full Text] [Related]
9. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma. Lee M, Jeon JY, Neugent ML, Kim JW, Yun M. Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188 [Abstract] [Full Text] [Related]
10. Dynamic PET of human liver inflammation: impact of kinetic modeling with optimization-derived dual-blood input function. Wang G, Corwin MT, Olson KA, Badawi RD, Sarkar S. Phys Med Biol; 2018 Jul 24; 63(15):155004. PubMed ID: 29847315 [Abstract] [Full Text] [Related]
11. Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma. Yang JF, Zhao ZH, Zhang Y, Zhao L, Yang LM, Zhang MM, Wang BY, Wang T, Lu BC. World J Gastroenterol; 2016 Apr 07; 22(13):3652-62. PubMed ID: 27053857 [Abstract] [Full Text] [Related]
12. Dynamic chaotic gravitational search algorithm-based kinetic parameter estimation of hepatocellular carcinoma on 18F-FDG PET/CT. He J, Wang T, Li Y, Deng Y, Wang S. BMC Med Imaging; 2022 Feb 06; 22(1):20. PubMed ID: 35125095 [Abstract] [Full Text] [Related]
13. HRD1 attenuates the high uptake of [18F]FDG in hepatocellular carcinoma PET imaging. Li AM, Lin XW, Shen JT, Li M, Zheng QH, Zhou ZY, Shi M. Nucl Med Biol; 2021 Feb 06; 96-97():27-34. PubMed ID: 33725499 [Abstract] [Full Text] [Related]
14. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation. Lin CY, Liao CW, Chu LY, Yen KY, Jeng LB, Hsu CN, Lin CL, Kao CH. Clin Nucl Med; 2017 Apr 06; 42(4):e183-e187. PubMed ID: 28114226 [Abstract] [Full Text] [Related]
15. High-Temporal-Resolution Kinetic Modeling of Lung Tumors with Dual-Blood Input Function Using Total-Body Dynamic PET. Wang Y, Abdelhafez YG, Spencer BA, Verma R, Parikh M, Stollenwerk N, Nardo L, Jones T, Badawi RD, Cherry SR, Wang G. J Nucl Med; 2024 May 01; 65(5):714-721. PubMed ID: 38548347 [Abstract] [Full Text] [Related]
16. Feasibility of perfusion and early-uptake 18F-FDG PET/CT in primary hepatocellular carcinoma: a dual-input dual-compartment uptake model. Wang S, Li B, Li P, Xie R, Wang Q, Shi H, He J. Jpn J Radiol; 2021 Nov 01; 39(11):1086-1096. PubMed ID: 34076855 [Abstract] [Full Text] [Related]
17. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma. Ho CL, Chen S, Yeung DW, Cheng TK. J Nucl Med; 2007 Jun 01; 48(6):902-9. PubMed ID: 17504862 [Abstract] [Full Text] [Related]
18. Diagnostic value of combining ¹¹C-choline and ¹⁸F-FDG PET/CT in hepatocellular carcinoma. Castilla-Lièvre MA, Franco D, Gervais P, Kuhnast B, Agostini H, Marthey L, Désarnaud S, Helal BO. Eur J Nucl Med Mol Imaging; 2016 May 01; 43(5):852-859. PubMed ID: 26577938 [Abstract] [Full Text] [Related]